Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Bronchopulmory Dysplasia - Overview
Bronchopulmory Dysplasia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Bronchopulmory Dysplasia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Bronchopulmory Dysplasia - Companies Involved in Therapeutics Development
Advent Therapeutics Inc
Airway Therapeutics LLC
Ayuvis Research Inc
Chiesi Farmaceutici SpA
Insmed Inc
Laboratoire Aguettant SA
MediPost Co Ltd
Meridigen Biotech Co Ltd
Orphanix GmbH
Radikal Therapeutics Inc
Syntrix Biosystems Inc
Takeda Pharmaceutical Co Ltd
The Cell Factory BVBA
Trimunocor Ltd
United Therapeutics Corp
Windtree Therapeutics Inc
Bronchopulmory Dysplasia - Drug Profiles
Aerosurf - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AT-100 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AVR-48 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CFMEV-132 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs for Bronchopulmory Dysplasia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hydrocortisone hemisuccite - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
mecasermin rinfabate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody to Inhibit FLT1 for Bronchopulmory Dysplasia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Bronchopulmory Dysplasia - Dormant Projects
Bronchopulmory Dysplasia - Discontinued Products
Bronchopulmory Dysplasia - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Bronchopulmonary Dysplasia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Bronchopulmonary Dysplasia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Bronchopulmonary Dysplasia - Pipeline by Advent Therapeutics Inc, H2 2020
Bronchopulmonary Dysplasia - Pipeline by Airway Therapeutics LLC, H2 2020
Bronchopulmonary Dysplasia - Pipeline by Ayuvis Research Inc, H2 2020
Bronchopulmonary Dysplasia - Dormant Projects, H2 2020
Bronchopulmonary Dysplasia - Discontinued Products, H2 2020